Stocks to Watch: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Kohl's Corporation (NYSE:KSS), MAXIMUS, Inc. (NYSE:MMS)

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares rose Thursday, after the clinical-stage biopharmaceutical company reported its Q3 loss narrowed from the same period last year, and said it is continuing its discussions with multiple pharmaceutical companies to explore "collaborative business structures." Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares were up 1.6% at $0.72 per share recently, in a 52-week range of $0.37 to $1.85.The company, which isn't yet generating revenue, posted a Q3 net loss of $1.9 million, or $0.01 per share, compared with the prior-year period's net loss of $2.1 million, or $0.02 per share. The results include an unrealized gain in the current quarter and a loss in the prior-year period's quarter on the fair value of warrants amounting to $1.2 million and $0.2 million, respectively. Two analysts polled by Capital IQ were expecting a loss excluding one-time items of $0.02 per share, on average. The company said it is continuing its discussions with multiple pharmaceutical companies to explore collaborative business structures "in an effort to maximize the potential upside value of its Supinoxin and RX-3117 clinical development programs." Supinoxin is an orally administered small molecule inhibitor of phosphorylated-p68 RNA helicase, which is selectively expressed in cancer cells and is absent in normal tissue, increases the activity of multiple cancer related genes, and plays a role in tumor progression and metastasis.Click here for a free comprehensive Trend Analysis ReportKohl's Corporation (NYSE:KSS) the department-store operator posted lower fiscal Q3 earnings and revenue that missed analysts' expectations as same-store sales declined. For the quarter ended Nov. 1, 2014, the company posted net income of $142 million, or $$0.70 per diluted share, down from $177 million, or $0.81 per diluted share, for the quarter ended Nov. 2, 2013. Analysts polled by Capital IQ had been expecting a profit of $0.74 per share, on average.Net sales slipped 1.6% to $4.37 billion, slightly missing the $4.39 billion expected on average by the Street. Same-store sales were down 1.8%, versus a 1.6% decline in the prior-year period. Kohl's Corporation (NYSE:KSS) maintained its quarterly dividend rate, a quarterly cash dividend on its common stock of $0.39 per share. The dividend is payable Dec. 24 to shareholders of record at the close of business on Dec. 10.Click here for a free comprehensive Trend Analysis ReportMAXIMUS, Inc. (NYSE:MMS), a government services provider, announced fiscal Q4 results that beat the Street view on EPS but fell short on total revenues. The company reported Q3 EPS of $0.53, up from $0.51 in Q4 2013 and beating analyst estimates of $0.52. Total revenues of $435.40 million were up from $384.33 million in Q4 2013 but fell short of analyst projections of $447.67 million. MAXIMUS, Inc. (NYSE:MMS) established its fiscal year 2015 revenue and earnings guidance on October 28. The company expects fiscal year 2015 revenue to range between $1.9 billion and $2.0 billion and expects diluted earnings per share to range between $2.25 and $2.40."For fiscal 2015, MAXIMUS is forecasting top-line growth in the range of 12% to 18% and we estimate that approximately 90% of our forecasted 2015 revenue, based upon the midpoint of our revenue guidance range, is already in the form of backlog or option periods," said Richard A. Montoni, MAXIMUS Chief Executive Officer. Shares of MMS are at $50.33 within a 52-week range of $37.94 -$50.69.Click here for a free comprehensive Trend Analysis Report